Core Laboratories N.V. (CLB): Price and Financial Metrics


Core Laboratories N.V. (CLB)

Today's Latest Price: $10.82 USD

0.37 (3.54%)

Updated Apr 8 3:11pm

Add CLB to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 60 in Energy - Services

See all "A" rated Strong Buy stocks

CLB Stock Summary

  • The capital turnover (annual revenue relative to shareholder's equity) for CLB is 3.76 -- better than 86.86% of US stocks.
  • CLB's current price/earnings ratio is 4.75, which is higher than just 12.74% of US stocks with positive earnings.
  • In terms of volatility of its share price, CLB is more volatile than 87.07% of stocks we're observing.
  • If you're looking for stocks that are quantitatively similar to Core Laboratories N V, a group of peers worth examining would be FSV, MARA, GHSI, PAGS, and RYB.
  • Visit CLB's SEC page to see the company's official filings. To visit the company's web site, go to www.corelab.com.
CLB Daily Price Range
CLB 52-Week Price Range

CLB Stock Price Chart More Charts


CLB Price/Volume Stats

Current price $10.82 52-week high $75.63
Prev. close $10.45 52-week low $6.68
Day low $10.02 Volume 726,093
Day high $10.94 Avg. volume 1,442,227
50-day MA $21.71 Dividend yield 9.57%
200-day MA $39.25 Market Cap 480.88M

Core Laboratories N.V. (CLB) Company Bio


Core Laboratories provides proprietary and patented reservoir description, production enhancement, and reservoir management services used to optimize petroleum reservoir performance. The company was founded in 1936 and is based in Amsterdam, the Netherlands.

CLB Price Forecast Based on DCF Valuation

Current PriceDCF Fair Value Target:Forecasted Gain:
$10.82$5.54-47%

The table below illustrates the output of a discounted cash flow forecast using a variety of scenarios for Core Laboratories N V. To summarize, we found that Core Laboratories N V ranked in the 26th percentile in terms of potential gain offered. We should note, though, that all scenearios modelled for this stock suggest it is overvalued. As for the metrics that stood out in our discounted cash flow analysis of Core Laboratories N V, consider:

  • The company's compound free cash flow growth rate over the past 5.55 years comes in at -0.21%; that's greater than just 9.04% of US stocks we're applying DCF forecasting to.
  • Core Laboratories N V's weighted average cost of capital (WACC) is 6%; for context, that number is higher than just 8.75% of tickers in our DCF set.
  • The company's cost of debt, derived from its interest coverage, tax rate, and market capitalization, is greater than merely 19.04% of stocks in its sector (Energy).


Terminal Growth Rate in Free Cash FlowReturn Relative to Current Share Price
0%-48%
1%-48%
2%-47%
3%-46%
4%-46%
5%-45%

EGY, PBA, RDS.A, VVV, and ENSV can be thought of as valuation peers to CLB, in the sense that they are in the Energy sector and have a similar price forecast based on DCF valuation.


CLB Latest News Stream


Event/TimeNews Detail
Loading, please wait...

CLB Latest Social Stream


Loading social stream, please wait...

View Full CLB Social Stream

CLB Price Returns

1-mo -19.97%
3-mo -72.78%
6-mo -75.01%
1-year -83.91%
3-year -89.83%
5-year -89.71%
YTD -71.09%
2019 -34.35%
2018 -44.49%
2017 -6.83%
2016 12.57%
2015 -7.83%

CLB Dividends

Ex-Dividend DateTypePayout AmountChange
Loading, please wait...
View Full CLB Dividend History

Continue Researching CLB

Want to see what other sources are saying about Core Laboratories N V's financials and stock price? Try the links below:

Core Laboratories N V (CLB) Stock Price | Nasdaq
Core Laboratories N V (CLB) Stock Quote, History and News - Yahoo Finance
Core Laboratories N V (CLB) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.7821 seconds.